Yahoo · Nov 11, 2026
Small cap Snapshot: Anteris expands trial, PilbaraGold expands mineralsiation and more...
Here’s a look at some of the small-cap companies in the news this Wednesday. Anteris Technologies has expanded its pivotal PARADIGM Trial across active sites in the United States, Canada and Europe, while also securing regulatory clearance in Germany and advancing activities in Australia. The company has also moved into a new Minnesota facility to support increased production of its transcatheter heart valve ahead of commercialisation. Third-quarter net operating cash outflows were US$22.9 million. Nova Minerals has confirmed around 216,000 tonnes a year of processing capacity at its planned Port MacKenzie hub in Alaska, with modelling pointing to potential refined antimony production of up to 20,000 tonnes annually. The first-phase refinery is targeting production of military-grade antimony trisulfide in 2027, supported by a US$43.4 million Department of War-backed project. Pilbara Gold has confirmed broad gold mineralisation around 200 metres below the current resource at its Mt York Gold Project, with the system remaining open at depth along a 4.2-kilometre mineralised trend. A new resource estimate and pre-feasibility study are targeted for 2027, while completed infill drilling is expected to improve confidence in the existing 2.1-million-ounce resource. Assays are still pending for 27 holes, mostly at Main Hill Extension. And Aruma Resources has extended the shallow, high-grade Tillex copper-silver zone in Ontario to around 245 metres of strike, with mineralisation still open in all directions. The latest hole returned 27.7 metres at 1.51% copper and 5.69 grams per tonne silver from 49.3 metres. Assays are pending for another eight holes, with Phase 2 drilling expected to continue into early January. Follow Proactive and subscribe on YouTube, across our social channels and at proactiveinvestors.com.
